Genomic Valley Biotech Limited

₹52.76As of Sun 8 Nov 2026, 12:00 UTC
BSE:539206—
Country India
PE (Fwd) •••
TSR 7Y CAGR 31.53%
Div yield —
ROE (0.07%)
Agricultural Production Crops
Beta (5Y) (0.45)
PE TTM —
TSR TTM 73.55%
Mkt cap ₹161.2M
ROIC (0.07%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹51
(3.76%)
(75.32%)
Buy 2|0|1|7|2
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.68
0.68
0.73
0.78
11.03%
10.76%
21.38%
23.98%
Revenue₹M
8.546
8.748
8.752
9.101
6.11%
10.69%
5.47%
10.92%
Peers (US$1.806M)
Cap (US$)
PE
1.528M
27.09x
Capital
TTM
5Y
10Y
Leveragex
0.128
(0.056)
(0.056)
EBIT/Intx
0.638
0.295
0.291
Own earn%
175.32
23.36
16.69
Sh yield%
26.63
45.37
46.56
Owners
Insiders/Inst%
4.04
67.94
Short interest%
1.70
SBC / revenue%
0.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
14–18
$1 testx
2.7
Incr. ROIC%
62